Assessment of the Effectiveness of Menopur in Intrauterine Insemination

NCT01354834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2025-03-28

No results posted yet for this study

Summary

The purpose of this study is to assess the effectiveness of Menopur to achieve clinical pregnancy in females undergoing intrauterine insemination in clinical practice.

Conditions

Interventions

DRUG

hMG

Patients with a condition

Sponsors & Collaborators

  • Ferring SAU

    collaborator INDUSTRY
  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2005-12-31
Completion
2006-04-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01354834 on ClinicalTrials.gov